1 week Ago By ABMN Staff
Orion Portfolio Solutions LLC lowered its position in Align Technology, Inc. ( NASDAQ:ALGN – Free Report ) by 39.4% during the fourth quarter, according to its most recent filing with the SEC.
The firm owned 1,792 shares of the medical equipment provider’s stock after selling 1,166 shares during the period. Orion Portfolio Solutions LLC’s holdings in Align Technology were worth $374,000 as of its most recent filing with the SEC. Other hedge funds and other institutional investors have also bought and sold shares of the company.
Neo Ivy Capital Management acquired a new position in shares of Align Technology during the 3rd quarter valued at $32,000. Picton Mahoney Asset Management grew its position in Align Technology by 69.9% in the 4th quarter.
Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 58 shares in the last quarter. Private Trust Co. NA increased its position in shares of Align Technology by 113.
4% during the fourth quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 93 shares during the last quarter.
Quarry LP raised its stake in shares of Align Technology by 74.8% during the 3rd quarter. Quarry LP now owns 222 shares of the medical equipment provider’s stock worth $56,000 after purchasing an additional 95 shares during the period.
Finally, Versant Capital Management Inc raised its holdings in shares of Align Technology by 212.2% in the 4th quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock worth $48,000 after purchasing an additional 157 shares during the period.
Institutional investors and hedge funds own 88.43% of the company’s stock. Wall Street Analysts Forecast Growth Several research firms recently commented on ALGN.
Piper Sandler reaffirmed an “overweight” rating and issued a $235.00 price objective (down from $270.00) on shares of Align Technology in a report on Tuesday, March 18th.
Leerink Partners raised Align Technology from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $235.00 to $280.00 in a report on Monday, January 6th.
Bank of America increased their target price on Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research note on Friday, December 13th.
Jefferies Financial Group decreased their price target on shares of Align Technology from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Thursday, January 23rd.
Finally, Leerink Partnrs raised Align Technology from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.
com, the stock has a consensus rating of “Moderate Buy” and an average target price of $262.64. Align Technology Stock Down 5.
9 % ALGN opened at $144.32 on Wednesday. Align Technology, Inc.
has a 52 week low of $141.74 and a 52 week high of $331.64.
The stock has a market cap of $10.57 billion, a PE ratio of 25.73, a PEG ratio of 2.
24 and a beta of 1.73. The business has a 50 day moving average of $181.
68 and a 200-day moving average of $209.43. Align Technology ( NASDAQ:ALGN – Get Free Report ) last posted its quarterly earnings results on Wednesday, February 5th.
The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.
47). Align Technology had a return on equity of 13.84% and a net margin of 10.
54%. Equities analysts anticipate that Align Technology, Inc. will post 7.
98 EPS for the current year. Align Technology Company Profile ( Free Report ) Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Articles Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter ..
